Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price dropped 1.9% during trading on Friday . The stock traded as low as $49.70 and last traded at $49.70. Approximately 344 shares changed hands during trading, a decline of 65% from the average daily volume of 989 shares. The stock had previously closed at $50.66.
Hikma Pharmaceuticals Trading Down 1.9 %
The firm has a fifty day moving average of $49.25 and a 200 day moving average of $48.54.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- How Technical Indicators Can Help You Find Oversold Stocks
- McDonald’s Stock: Balancing Value and Innovation
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 6/17 – 6/21
- Investing in large cap stocks: Diving into big caps
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
